HIV Drug Based in Research by Sundquist Lab is Science’s 2024 Breakthrough of the Year
Lenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MoreLenacapavir provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Read MoreMirror-reversed synthetic organisms could aid drug development–but could also interact with humans and the environment in unpredictable, potentially dangerous ways.
Read MoreCollege of Health explores how VR technology can fast track recovery for those undergoing rehabilitation after strokes.
Read MoreAstronauts have a higher risk of blood clots. To learn why, scientists are sending blood cells to the International Space Station.
Read MoreDIADEM developer Jan Kubanek named Founder of the Year and Utah Bionic leg Breakthrough of the Year at event honoring Utah’s innovators
Read MorePreventing the protein’s activity causes parasites to die unusually rapidly.
Read MoreThe center aims to advance research, improve clinical care, support affected families, and reshape public understanding of stillbirth.
Read MoreResearchers aim to improve risk prediction and medical image analysis while ensuring reliability, privacy, and fairness.
Read MoreQ&A with political scientist Matthew Burbank on what’s in it for Olympic host cities as Utah gears up for 2034 Winter Games.
Read More